MétaCan
Menu
Back to cohort
Record W2504858853 · doi:10.1016/j.ekir.2016.06.009

ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap

2016· article· en· W2504858853 on OpenAlexaff
Hans‐Joachim Anders, Brad H. Rovin, David Jayne, Paul Brunetta, Rosanna Coppo, Anne Davidson, Satish Kumar Devarapu, Dick de Zeeuw, Jeremy S. Duffield, Dirk Eulberg, Alberto Fierro, Jürgen Floege, Steffen Frese, Loı̈c Guillevin, Stephen R. Holdsworth, Jeremy Hughes, Ralph Kettritz, Malte A. Kluger, Christian F. Krebs, Larissa Lapteva, Adeera Levin, Jinhua Li, Liz Lightstone, Matthias Mack, Ladan Mansouri, Stephen P. McAdoo, Eoin McKinney, Ulf Panzer, Samir M. Parikh, Charles D. Pusey, Chaim Putterman, Ton J. Rabelink, Andreas Radbruch, Andrew J. Rees, Mary M. Reilly, Marlies E. J. Reinders, Giuseppe Remuzzi, Piero Ruggenenti, Steven H. Sacks, Thomas J. Schall, Catherine Meyer‐Schwesinger, Kumar Sharma, Yusuke Suzuki, Nicola M. Tomas, Ming‐Hui Zhao

Bibliographic record

VenueKidney International Reports · 2016
Typearticle
Languageen
FieldMedicine
TopicRenal Diseases and Glomerulopathies
Canadian institutionsUniversity of British Columbia
FundersFondo Nacional de Desarrollo Científico y TecnológicoEuropean CommissionInternational Society of Nephrology
KeywordsTranslational researchMedicineNexus (standard)Translational medicineTranslational scienceNephrologyDrug developmentDiseaseKidney diseaseBioinformaticsInternal medicineDrugPharmacologyPathologyBiologyEngineering

Abstract

fetched live from OpenAlex

To date, the treatment of immune-mediated kidney diseases has only marginally benefited from highly specific biological drugs that have demonstrated remarkable effects in many other diseases. What accounts for this disparity? In April 2016, the International Society of Nephrology held a Nexus meeting on Translational Immunology in Nephrology in Berlin, Germany, to identify and discuss hurdles that block the translational flow of target identification, and preclinical and clinical target validation in the domain of immune-mediated kidney disease. A broad panel of experts including basic scientists, translational researchers, clinical trialists, pharmaceutical industry drug developers, and representatives of the American and European regulatory authorities made recommendations on how to overcome such hurdles at all levels of the translational research process. The results of these discussions are presented here, which may serve as a roadmap for how to optimize the process of developing more innovative and effective drugs for patients with immune-mediated kidney diseases.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.009
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: none
Teacher disagreement score0.031
Threshold uncertainty score0.105

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0150.009
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0010.002
Scholarly communication0.0060.004
Open science0.0010.006
Research integrity0.0050.010
Insufficient payload (model declined to judge)0.0310.013

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.263
Teacher spread0.254 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEditorial

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueKidney International ReportsSame topicRenal Diseases and GlomerulopathiesFrench-language works237,207